This contract shall provide lymphokine-activated killer (LAK) cells for use by the Surgery Branch, NCI in on-going clinical trials. Production of human LAK cells are to be performed for 3 patients per week. These cells will be derived from the patients' peripheral blood by multiple leukopheresis and will be supplied by the Surgery. Each patient that is leukopheresed will yield approximately 3-7 X 1010 cells daily. The number of patients and any modifications of cell activation will be at the discretion of the Project Officer.

Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CM087236-000
Application #
3615770
Study Section
Project Start
1988-03-15
Project End
1991-03-14
Budget Start
1988-03-15
Budget End
1989-03-14
Support Year
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Advanced Bioscience Laboratories, Inc.
Department
Type
DUNS #
City
Kensington
State
MD
Country
United States
Zip Code
20895